ASCO20 Virtual is about to begin, and the challenge is finding a way to interact and engage with presenters and other experts in a way we have never done before, writes Dr. Lidia Schapira.
By holding its scientific program on time, ASCO and the entire oncology community make a pledge that we will continue advancing and offering the best care for our patients worldwide.
Dr. Martina Murphy, Dr. Devika Das, and Dr. Elizabeth Henry consider how the COVID-19 pandemic is affecting hematology/oncology training, and offer tips for staying connected to trainees.
The 8th Annual Beirut Breast Cancer Conference featured an engaging opening debate, important discussions about adherence to guidelines and multidisciplinary care, and breast tumor boards.
As we begin our work in 2020, I am excited that we are building on the remarkable successes of 2019, and the years before, with growing collaboration and sharpening focus.
What does the future of immuno-oncology look like? Dr. Elizabeth A. Mittendorf invites you to be part of the conversation at the 2020 ASCO-SITC Clinical Immuno-Oncology Symposium in February.